These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 28056565

  • 1. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.
    Greig JA, Wang Q, Reicherter AL, Chen SJ, Hanlon AL, Tipper CH, Clark KR, Wadsworth S, Wang L, Wilson JM.
    Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565
    [Abstract] [Full Text] [Related]

  • 2. Optimized Adeno-Associated Viral-Mediated Human Factor VIII Gene Therapy in Cynomolgus Macaques.
    Greig JA, Nordin JML, White JW, Wang Q, Bote E, Goode T, Calcedo R, Wadsworth S, Wang L, Wilson JM.
    Hum Gene Ther; 2018 Jul 23. PubMed ID: 29890905
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
    McIntosh J, Lenting PJ, Rosales C, Lee D, Rabbanian S, Raj D, Patel N, Tuddenham EG, Christophe OD, McVey JH, Waddington S, Nienhuis AW, Gray JT, Fagone P, Mingozzi F, Zhou SZ, High KA, Cancio M, Ng CY, Zhou J, Morton CL, Davidoff AM, Nathwani AC.
    Blood; 2013 Apr 25; 121(17):3335-44. PubMed ID: 23426947
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
    Pasi KJ, Rangarajan S, Mitchell N, Lester W, Symington E, Madan B, Laffan M, Russell CB, Li M, Pierce GF, Wong WY.
    N Engl J Med; 2020 Jan 02; 382(1):29-40. PubMed ID: 31893514
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A.
    Evans GL, Morgan RA.
    Proc Natl Acad Sci U S A; 1998 May 12; 95(10):5734-9. PubMed ID: 9576953
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice.
    Sarkar R, Mucci M, Addya S, Tetreault R, Bellinger DA, Nichols TC, Kazazian HH.
    Hum Gene Ther; 2006 Apr 12; 17(4):427-39. PubMed ID: 16610930
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice.
    Ishiwata A, Mimuro J, Mizukami H, Kashiwakura Y, Takano K, Ohmori T, Madoiwa S, Ozawa K, Sakata Y.
    J Gene Med; 2009 Nov 12; 11(11):1020-9. PubMed ID: 19757487
    [Abstract] [Full Text] [Related]

  • 14. Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A.
    Long BR, Veron P, Kuranda K, Hardet R, Mitchell N, Hayes GM, Wong WY, Lau K, Li M, Hock MB, Zoog SJ, Vettermann C, Mingozzi F, Schweighardt B.
    Mol Ther; 2021 Feb 03; 29(2):597-610. PubMed ID: 33309883
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice.
    Peng B, Ye P, Blazar BR, Freeman GJ, Rawlings DJ, Ochs HD, Miao CH.
    Blood; 2008 Sep 01; 112(5):1662-72. PubMed ID: 18574023
    [Abstract] [Full Text] [Related]

  • 17. High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice.
    Xu L, Mei M, Ma X, Ponder KP.
    J Thromb Haemost; 2007 Sep 01; 5(9):1805-12. PubMed ID: 17596134
    [Abstract] [Full Text] [Related]

  • 18. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein.
    Burton M, Nakai H, Colosi P, Cunningham J, Mitchell R, Couto L.
    Proc Natl Acad Sci U S A; 1999 Oct 26; 96(22):12725-30. PubMed ID: 10535990
    [Abstract] [Full Text] [Related]

  • 19. Induction of tolerance to human factor VIII in mice.
    Chao H, Walsh CE.
    Blood; 2001 May 15; 97(10):3311-2. PubMed ID: 11342466
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.
    Nambiar B, Cornell Sookdeo C, Berthelette P, Jackson R, Piraino S, Burnham B, Nass S, Souza D, O'Riordan CR, Vincent KA, Cheng SH, Armentano D, Kyostio-Moore S.
    Hum Gene Ther Methods; 2017 Feb 15; 28(1):23-38. PubMed ID: 28166648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.